Celecoxib modulates nitric oxide and reactive oxygen species in kidney ischemia/reperfusion injury and rat aorta model of hypoxia/reoxygenation (Q46896166)

From Wikidata

Jump to navigation Jump to search

scientific article published on 6 May 2014

Language	Label	Description	Also known as
English	Celecoxib modulates nitric oxide and reactive oxygen species in kidney ischemia/reperfusion injury and rat aorta model of hypoxia/reoxygenation	scientific article published on 6 May 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24811609

Celecoxib modulates nitric oxide and reactive oxygen species in kidney ischemia/reperfusion injury and rat aorta model of hypoxia/reoxygenation (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24811609

0 references

reperfusion injury

1 reference

based on heuristic

inferred from title

reactive oxygen species

1 reference

based on heuristic

inferred from title

author name string

A M Senbel

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24811609

L AbdelMoneim

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24811609

A G Omar

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24811609

publication date

6 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24811609

Vascular Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24811609

62

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24811609

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24811609

24-31

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24811609

Protective effect of nitric oxide pathway in resveratrol renal ischemia-reperfusion injury in rats

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Effects of N-acetylcysteine on arginase, ornithine and nitric oxide in renal ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

The role of cycloxygenase-2 in the rodent kidney following ischaemia/reperfusion injury in vivo

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Preventive effects of COX-2 inhibitor, celecoxib on renal tubular injury induced by shock wave lithotriptor

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Renal effects of nabumetone, a COX-2 antagonist: impairment of function in isolated perfused rat kidneys contrasts with preserved renal function in vivo

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Rofecoxib decreases renal injury in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Ischemic acute renal failure: an inflammatory disease?

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Cyclooxygenase 1 and/or 2 blockade ameliorates the renal tissue damage triggered by ischemia and reperfusion injury

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Inhibition of COX 1 and 2 prior to renal ischemia/reperfusion injury decreases the development of fibrosis

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Nonimmunologic renal allograft injury and delayed graft function: clinical strategies for prevention and treatment

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

A rapid and precise method for the determination of urea

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Nitric oxide and renal protection in morphine-dependent rats.

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Effect of glutathione depletion on tissue deposition of methylmercury in rats

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Heterogeneous distribution of endothelium-dependent relaxations resistant to NG-nitro-L-arginine in rats

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Renal hypoxia and dysoxia after reperfusion of the ischemic kidney

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Effects of intrarenal administration of the cox-2 inhibitor parecoxib during porcine suprarenal aortic cross-clamping

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

The effect of celecoxib, a selective COX-2 inhibitor, on liver ischemia/reperfusion-induced oxidative stress in rats

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Selective COX-2 inhibition improves endothelial function in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Cyclooxygenase 2: a molecular target for cancer prevention and treatment

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1,

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Cyclooxygenase-2-dependent superoxide generation contributes to age-dependent impairment of G protein-mediated cerebrovasodilation

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension.

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Renal vascular dysfunction precedes the development of renal damage in the hypertensive Fawn-Hooded rat

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout.

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Involvement of alpha-receptors and potassium channels in the mechanism of action of sildenafil citrate

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Differential effects of the phosphodiesterase type 5 inhibitors sildenafil, vardenafil, and tadalafil in rat aorta

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Assessment of the endothelial functions in monocrotaline-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

PDEs1-5 activity and expression in tissues of cirrhotic rats reveal a role for aortic PDE3 in NO desensitization

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Celecoxib-induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G.

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Inhibition of cGMP-specific phosphodiesterase type 5 reduces sodium excretion and arterial blood pressure in patients with NaCl retention and ascites.

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Sildenafil improves immediate posttransplant parameters in warm-ischemic kidney transplants: experimental study

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2014.04.004

7 January 2021

Identifiers

10.1016/J.VPH.2014.04.004

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24811609

release_um6rluxrmrginczf7dwv5o7fau

1 reference

https://api.fatcat.wiki/v0/release/um6rluxrmrginczf7dwv5o7fau

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/24811609

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46896166&oldid=2136947068"